iBio, Inc. - 8-K Filing
iBio reports Q1 fiscal year 2027 revenue of $1.1 million and a net loss of $7.6 million for the quarter ended September 30, 2026. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $IBIO
Read the full article at SEC EDGAR
Part of the story Coincheck Reports Q2 2027 Net Loss Amid Declining Trading Volumes (2 articles)